Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

HOLX Balance Sheet

Assets, liabilities, and equity analysis

HOLX Quarterly Balance Sheet (USD)

Quarterly ReportTTM
12/27/2025
09/27/2025
06/28/2025
03/29/2025
12/28/2024
09/30/2024
06/29/2024
03/30/2024
Total Current Assets
3.843B3.843B3.668B3.421B3.209B3.494B3.823B3.997B3.789B
2.168B2.168B1.960B1.735B1.429B1.782B2.160B2.439B2.180B
Short-Term Investments
196.700M196.700M243.200M143.900M191.500M190.600M173.400M0.000.00
Cash & Short-Term Investments
2.365B2.365B2.203B1.879B1.621B1.973B2.334B2.439B2.180B
584.200M584.200M600.800M609.300M644.400M631.400M600.400M628.500M647.100M
688.500M688.500M679.400M713.700M716.700M707.100M679.800M665.500M649.200M
Total Assets
9.181B9.181B9.015B8.806B8.545B8.729B9.156B8.890B8.714B
568.300M568.300M653.700M570.500M555.800M537.200M630.000M528.800M524.800M
3.645B3.645B3.641B3.644B3.624B3.423B3.443B3.291B3.292B
Intangible Assets
547.300M547.300M589.100M642.200M673.800M793.300M844.600M687.600M751.900M
Long-Term Investments
0.000.0078.500M0.000.0047.900M150.700M0.000.00
Total Current Liabilities
951.300M951.300M977.200M962.500M989.700M1.002B1.037B1.002B954.600M
201.100M201.100M193.400M192.700M208.600M236.700M203.800M202.000M202.500M
9.300M9.300M2.900M3.400M56.200M46.800M37.500M37.500M37.400M
Total Liabilities
3.936B3.936B3.967B3.964B3.926B3.955B4.026B3.939B3.870B
2.503B2.503B2.505B2.509B2.461B2.479B2.497B2.506B2.514B
2.520B2.520B2.627B2.522B2.531B2.540B2.658B2.559B2.568B
Net Debt (Cash)
352.300M352.300M667.300M787.300M1.101B758.300M497.800M120.100M388.500M
Total Shareholders' Equity
5.245B5.245B5.048B4.843B4.619B4.773B5.130B4.951B4.844B
Common Stock
3.000M3.000M3.000M3.000M3.000M3.000M3.000M3.000M3.000M
3.591B3.591B3.412B3.224B3.029B3.047B2.846B2.667B2.473B
4.044.043.753.553.243.493.693.993.97
0.480.480.520.520.550.530.520.520.53

HOLX Annual Balance Sheet (USD)

Annual Report
09/27/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
09/30/2020
09/30/2019
09/30/2018
Total Current Assets
3.668B3.823B4.184B3.862B3.169B2.222B1.793B1.723B
1.960B2.160B2.723B2.340B1.170B701.000M601.800M666.700M
Short-Term Investments
243.200M173.400M0.000.000.000.000.000.00
Cash & Short-Term Investments
2.203B2.334B2.723B2.340B1.170B701.000M601.800M666.700M
600.800M600.400M625.600M617.600M942.700M1.029B648.700M579.200M
679.400M679.800M617.600M623.700M501.200M395.100M444.900M384.100M
Total Assets
9.015B9.156B9.139B9.071B8.920B7.196B6.611B7.231B
653.700M630.000M579.700M550.500M648.300M572.200M470.900M478.200M
3.641B3.443B3.281B3.236B3.282B2.658B2.564B2.533B
Intangible Assets
589.100M844.600M888.600M1.281B1.659B1.308B1.460B2.399B
Long-Term Investments
78.500M150.700M15.500M5.500M9.500M11.400M54.100M8.800M
Total Current Liabilities
977.200M1.037B1.207B937.700M1.327B1.239B1.070B1.403B
193.400M203.800M175.200M197.700M215.900M178.800M186.500M192.200M
2.900M37.500M287.000M15.000M313.000M324.900M271.400M599.700M
Total Liabilities
3.967B4.026B4.122B4.195B4.701B4.489B4.332B4.802B
2.505B2.497B2.531B2.808B2.712B2.714B2.784B2.705B
2.627B2.658B2.904B2.922B3.145B3.147B3.110B3.362B
Net Debt (Cash)
667.300M497.800M181.600M582.100M1.974B2.446B2.508B2.696B
Total Shareholders' Equity
5.048B5.130B5.017B4.876B4.219B2.705B2.279B2.429B
Common Stock
3.000M3.000M3.000M3.000M3.000M2.900M2.900M2.900M
3.412B2.846B2.056B1.600B298.300M-1.573B-2.689B-2.494B
3.753.693.474.122.391.791.681.23
0.520.520.580.600.751.161.361.38

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini